Financial Synergies Wealth Advisors, Inc. Moderna, Inc. Transaction History

Financial Synergies Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$85.37 - $115.44 $22,708 - $30,707	-266 Reduced 53.2%	234 $24.9 Million
Q4 2023 Apr 04, 2024	BUY	$69.51 - $104.43 $15,014 - $22,556	216 Added 76.06%	500 $89.8 Million
Q3 2023 Apr 04, 2024	SELL	$96.41 - $126.61 $20,824 - $27,347	-216 Reduced 43.2%	284 $29.3 Million
Q4 2022 Apr 04, 2024	SELL	$118.38 - $210.04 $54,928 - $97,458	-464 Reduced 48.13%	500 $89.8 Million
Q3 2022 Apr 04, 2024	SELL	$118.07 - $194.18 $90,323 - $148,547	-765 Reduced 44.25%	964 $114 Million

Q2 2022 Apr 04, 2024	BUY	$117.13 - $176.59 $202,517 - $305,324	1,729 New	1,729 $247 Million

1,054

244M

12.1M

9.35M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $47.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Financial Synergies Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Synergies Wealth Advisors, Inc. with notifications on news.